A Trial Investigating Lu AF28996 in Healthy Adult Participants
Status:
COMPLETED
Trial end date:
2024-05-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate repeated doses of Lu AF28996 in healthy participants and co-administered with two other compounds, and in a separate cohort following co-administration with antibiotics, to see how well the doses are tolerated and what the body does to the drug after administering it.